In the pancreas, it enhances glucose-dependent insulin secretion whilst suppressing inappropriate glucagon release, thereby improving glycaemic control
Achievement of Minimal Residual Disease Clearance is a Stronger Predictor of Patient Outcome Than Treatment Intensity in Newly Diagnosed Acute Myeloid Leukemia Patients
As the medication's appetite-suppressing effects wane, many patients experience a return of previous hunger patterns, which may lead to weight regain if dietary habits are not maintained
As a recent graduate, Im deeply inspired by the potential this research holds not only for advancing our scientific understanding, but also for paving the way toward future therapies, said Quddos, who earned her doctorate from Virginia Techs Translational Biology, Medicine, and Health Graduate Program in May
Both tirzepatide and semaglutide are FDA-approved, have support from more long-term data, and are already used in real-life settings
Key players like Kyowa Hakko Bio Co are driving innovation and expanding product offerings